Page 37 - tmp

ANALYSIS OF ANTIHZPERTENSIVETHERAPYIN PATIENTS WITH

ISCHEMIC STROKE
Filip Bošković
Zemunska gimnazija, Zemun, filipbos26@gmail.com

1. The purpose of the investigation
No changes Doses Second AH drug CCTP
A stroke is the loss of brain function due to disturbance in
the blood supply to the brain.Recent studies in Serbia show TIA 12(19,1%) 21(33,4) 27(42,8) 3(4,7)
that ischemic stroke (IMU) is the first cause of all deaths in
IS 9(17,6%) 12(23,6) 24(47) 6(11,8)
hospital, and is the second leading cause of death worldwide
and an important cause of serious, long-term disability. The
aim of the research is the analysis of therapeutic program ISS 33(17,7%) 57(30,5) 75(40,5) 21(11,2)
from the aspect of increased risk for the emergence and
Total 54(18%) 90(30,0%) 126(42%) 30(10,0%)
development of ischemic stroke, in patients with ischemic
stroke (IS), who were previously been on antihypertensive
(AH) therapy. Tabel 2. Analysis of the therapeutic program in comparison
to change modalities and degree of IS severity
2. Methods of the investigation
In 18% of cases did not need to change the AH program,in
The study included 300 patients (210 men and 90 women) 30% of cases, adequate control has been achieved by
with AIS who had elevated blood pressure (21‚3 with 12,7 increasing the dose of already attributed drugs. Utilizationof
kPa)before admission, who are known for hypertension and second AH drugwas requiredin 42% and a complete change
were on the AH therapy. The average age was 65.67 of the program in 10% of cases.It has been shown that 18%
years.All respondents were taken, a detailed history of the tookn regular therapy and check-ups and that 34% of
type AH drugs, therapy regularity and check-ups regularity. patientsirregularly use therapy and are controlled irregularly.
AH therapy includedcalcium channel blockers, beta
blockers,ACE inhibitorsanddiuretics.Transient ischemic 4. Conclusion
attack (TIA)was measuredthe first 24 hours at 4 hours, and
then 3 times per day. From the study were excluded patients It has been shownthat diureticswere the most commonly
with certain types of illnesses due to the inability to obtain used AH drugs. To nearly half of patients were introduced
valid data. second AH drug due to differences in the type of illness and
specificity of patients.Because of the fact that patients do not
3. Results realize seriousness of the event that they survived and that in
a short period after a stroke give up the recommended
therapeutic program and the fact that the profession
Ca blockers B blockers ACE inhibitors Diuretics
insufficiently insisted on the necessity of a rigorous
adherence to treatment protocols, neurologists and society
TIA 24(57,1%) 21(33,3%) 33(52,3%) 30(47,6%) today have a big problem.

IS 27(52,9%) 15(29,4%) 27(52,9%) 33(64,7%)
REFERENCES

ISS 102(55%) 51(27,4%) 96(51.6%) 108(58%)
[1] Albers GW, Easton JD, Sacco RL, Teal P.
Antithrombotic and thrombolytic therapy for ischemic
Tabel 1. The frequency of AH therapy compared to the stroke. Chest. 1998;114:683S-698S.
degree of severity of IS
[2] Ţivković M, Šternić N, Kostić V. Ishemička bolest
Diuretics are most commonly applied AH drugs (alone or in mozga. Beograd: Zavod za udţbenike i nastavna sredstva,
combination in 58% of cases), calcium channel blockers in 2000.
55%, ACE inhibitors52%, beta blockers 29%.

Acknowledgment: to colonel prof. D.N. Ranko Raičević, head of the Clinic of Neurology (MMA), for support and permission to
take part in the regular activities of theClinic of Neurology